Basal cell carcinoma (BCC) is that the commonest carcinoma in Caucasians and its incidence continues to extend worldwide [1]. First described in 1824 by Jacob, it's a slow growing, locally destructive, skin tumour of the epidermis [2]. Average life time risk of developing a BCC is approximately 30% in Caucasians, and represents a big public health issue .
Australia has the very best incidence of BCC in world with 1383 new cases diagnosed for each 100,000 population in 2008 [4]. In UK there are estimated 53,000 new cases per annum , and 153.9 cases per 100, 000 person years .
Figures for incidence are likely to be significantly underestimated in the UK as BCCs are not routinely registered.
Editorial: Journal of Cancer Clinical Trials
Editorial: Journal of Cancer Clinical Trials
Editorial: Journal of Cancer Clinical Trials
Editorial: Journal of Cancer Clinical Trials
Editorial: Journal of Cancer Clinical Trials
Editorial: Journal of Cancer Clinical Trials
Scientific Tracks Abstracts: Journal of AIDS & Clinical Research
Scientific Tracks Abstracts: Journal of AIDS & Clinical Research
Scientific Tracks Abstracts: Journal of AIDS & Clinical Research
Scientific Tracks Abstracts: Journal of AIDS & Clinical Research
Keynote: Journal of AIDS & Clinical Research
Keynote: Journal of AIDS & Clinical Research
Posters & Accepted Abstracts: Journal of Cosmetology & Trichology
Posters & Accepted Abstracts: Journal of Cosmetology & Trichology
Journal of Cancer Clinical Trials received 95 citations as per Google Scholar report